<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><link type="text/css" rel="stylesheet" href="resources/sheet.css" >
<style type="text/css">.ritz .waffle a { color: inherit; }.ritz .waffle .s0{background-color:#ffffff;text-align:left;font-weight:bold;color:#000000;font-family:docs-Roboto,Arial;font-size:12pt;vertical-align:middle;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s2{border-right:3px SOLID #000000;background-color:#000000;text-align:left;font-weight:bold;color:#ffffff;font-family:docs-Roboto,Arial;font-size:12pt;vertical-align:middle;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s4{border-right:3px SOLID #000000;background-color:#ffffff;text-align:center;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;font-family:docs-Roboto,Arial;font-size:12pt;vertical-align:middle;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s7{border-bottom:3px SOLID #000000;background-color:#ffffff;text-align:left;font-weight:bold;color:#000000;font-family:docs-Roboto,Arial;font-size:12pt;vertical-align:middle;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s1{border-right:3px SOLID #000000;background-color:#ffffff;text-align:left;font-weight:bold;color:#000000;font-family:docs-Roboto,Arial;font-size:12pt;vertical-align:middle;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s8{border-bottom:3px SOLID #000000;background-color:#ffffff;text-align:left;color:#000000;font-family:docs-Roboto,Arial;font-size:12pt;vertical-align:middle;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s9{border-bottom:3px SOLID #000000;border-right:3px SOLID #000000;background-color:#ffffff;text-align:center;color:#000000;font-family:docs-Roboto,Arial;font-size:12pt;vertical-align:middle;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s6{border-right:3px SOLID #000000;background-color:#ffffff;text-align:center;color:#000000;font-family:docs-Roboto,Arial;font-size:12pt;vertical-align:middle;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s5{background-color:#ffffff;text-align:left;color:#000000;font-family:"docs-Liberation Sans",Arial;font-size:8pt;vertical-align:middle;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s3{background-color:#ffffff;text-align:left;color:#000000;font-family:docs-Roboto,Arial;font-size:12pt;vertical-align:middle;white-space:normal;overflow:hidden;word-wrap:break-word;direction:ltr;padding:2px 3px 2px 3px;}</style><div class="ritz grid-container" dir="ltr"><table class="waffle" cellspacing="0" cellpadding="0"><thead><tr><th class="row-header freezebar-vertical-handle"></th><th id="470178436C0" style="width:300px;" class="column-headers-background">A</th><th id="470178436C1" style="width:300px;" class="column-headers-background">B</th><th id="470178436C2" style="width:300px;" class="column-headers-background">C</th><th id="470178436C3" style="width:300px;" class="column-headers-background">D</th><th id="470178436C4" style="width:300px;" class="column-headers-background">E</th><th id="470178436C5" style="width:300px;" class="column-headers-background">F</th></tr></thead><tbody><tr style="height: 20px"><th id="470178436R0" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">1</div></th><td class="s0" dir="ltr">Therapeutic Approach</td><td class="s0" dir="ltr">Description</td><td class="s0" dir="ltr">Pros</td><td class="s0" dir="ltr">Cons</td><td class="s0" dir="ltr">Applicability</td><td class="s1" dir="ltr">References</td></tr><tr><th style="height:3px;" class="freezebar-cell freezebar-horizontal-handle"></th><td class="freezebar-cell"></td><td class="freezebar-cell"></td><td class="freezebar-cell"></td><td class="freezebar-cell"></td><td class="freezebar-cell"></td><td class="freezebar-cell"></td></tr><tr style="height: 20px"><th id="470178436R1" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">2</div></th><td class="s2" dir="ltr" colspan="6">Symptomatic Treatments</td></tr><tr style="height: 20px"><th id="470178436R2" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">3</div></th><td class="s0" dir="ltr">Physical aids (e.g., walking aids)</td><td class="s3" dir="ltr">Aims to compensate for muscle weakness</td><td class="s3" dir="ltr">Improves mobility and independence</td><td class="s3" dir="ltr">Does not address underlying disease</td><td class="s3" dir="ltr">Widely used in clinical practice. Suitable for most patients</td><td class="s4" dir="ltr"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></td></tr><tr style="height: 20px"><th id="470178436R3" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">4</div></th><td class="s0" dir="ltr">Physiotherapy and occupational therapy</td><td class="s3" dir="ltr">Helps maintain muscle function and flexibility</td><td class="s3" dir="ltr">Reduces symptom progression</td><td class="s3" dir="ltr">Requires ongoing commitment</td><td class="s3" dir="ltr">Standard supportive care. Broad applicability</td><td class="s4" dir="ltr"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></td></tr><tr style="height: 20px"><th id="470178436R4" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">5</div></th><td class="s0" dir="ltr">Experimental drugs (e.g., ezetimibe)</td><td class="s3" dir="ltr">Counters abnormal fat accumulation</td><td class="s3" dir="ltr">Targets secondary effects</td><td class="s3" dir="ltr">Limited evidence in humans; potential side effects</td><td class="s3" dir="ltr">Early research stages. Limited to specific symptoms</td><td class="s4" dir="ltr"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></td></tr><tr style="height: 20px"><th id="470178436R5" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">6</div></th><td class="s0" dir="ltr">Glucocorticoids</td><td class="s3" dir="ltr">Anti-inflammatory and immunosuppressive</td><td class="s3" dir="ltr">Beneficial in other muscular dystrophies</td><td class="s3" dir="ltr">Adverse effects in dysferlinopathy, e.g., muscle weakness</td><td class="s3" dir="ltr">Clinical evidence suggests accelerated decline in muscle strength. Not recommended for dysferlinopathy</td><td class="s4" dir="ltr"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></td></tr><tr style="height: 20px"><th id="470178436R6" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">7</div></th><td class="s2" dir="ltr" colspan="6">Pharmacological Approaches</td></tr><tr style="height: 20px"><th id="470178436R7" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">8</div></th><td class="s0" dir="ltr">Proteasome inhibitors</td><td class="s3" dir="ltr">Reduce levels of TSP-1, a protein that exacerbates muscle inflammation and fibrosis</td><td class="s3" dir="ltr">Reduces inflammation and fibrosis</td><td class="s3" dir="ltr">May not directly affect dysferlin expression</td><td class="s3" dir="ltr">Preclinical and early clinical trials. Potentially applicable to a subset of patients</td><td class="s4" dir="ltr"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></td></tr><tr style="height: 20px"><th id="470178436R8" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">9</div></th><td class="s0" dir="ltr">Blockade of Hemichannels (boldine)</td><td class="s3" dir="ltr">Myoblasts with fat accumulation can be redirected towards normal muscle cell development</td><td class="s3" dir="ltr">This treatment potentially normalizes the differentiation of myoblasts and muscle features in BLA/J mice</td><td class="s5"></td><td class="s3" dir="ltr">Experimental. Long-term boldine treatment has shown improvement in motor activity and muscle features.</td><td class="s6" dir="ltr"><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></span><br><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.3390/ijms21176025">Cea et al. (2020)</a></span></td></tr><tr style="height: 20px"><th id="470178436R9" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">10</div></th><td class="s0" dir="ltr">Galectin-1 treatment</td><td class="s3" dir="ltr">Enhances myogenic potential and membrane repair</td><td class="s3" dir="ltr">Improves muscle repair capabilities</td><td class="s3" dir="ltr">Long-term effects unknown</td><td class="s3" dir="ltr">Experimental stage. Limited by stage of muscle degeneration</td><td class="s4" dir="ltr"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></td></tr><tr style="height: 20px"><th id="470178436R10" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">11</div></th><td class="s0" dir="ltr">N-acetylcysteine (NAC)</td><td class="s3" dir="ltr">Scavenges reactive oxygen species</td><td class="s3" dir="ltr">Reduces oxidative stress</td><td class="s3" dir="ltr">Efficacy in humans not fully established</td><td class="s3" dir="ltr">Preclinical and early clinical trials. Broad applicability for oxidative stress management</td><td class="s6" dir="ltr"><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></span><br><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.3390/ijms21124293">Carcia-Campos et al. (2020)</a></span></td></tr><tr style="height: 20px"><th id="470178436R11" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">12</div></th><td class="s0" dir="ltr">Diltiazem</td><td class="s3" dir="ltr">Calcium ion channel blocker, improves muscle contractility</td><td class="s3" dir="ltr">Improves muscle contractile properties</td><td class="s3" dir="ltr">Does not reduce muscle damage</td><td class="s3" dir="ltr">Preclinical evidence. Limited applicability; more research needed</td><td class="s6" dir="ltr"><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></span><br><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.14814/phy2.13727">Begam et al. (2018)</a></span></td></tr><tr style="height: 20px"><th id="470178436R12" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">13</div></th><td class="s0" dir="ltr">Halofuginone</td><td class="s3" dir="ltr">Enhances membrane repair and synaptotagmin-7 levels, increases lysosomal exocytotic activity</td><td class="s3" dir="ltr">Enhances membrane repair</td><td class="s3" dir="ltr">Limited human data; potential side effects</td><td class="s3" dir="ltr">Early clinical trials. Patients with severe membrane repair deficits</td><td class="s6" dir="ltr"><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></span><br><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.1093/hmg/ddy185">Barzila-Tutsh et al. (2018)</a></span></td></tr><tr style="height: 20px"><th id="470178436R13" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">14</div></th><td class="s2" dir="ltr" colspan="6">Molecular and Genetic Therapies</td></tr><tr style="height: 20px"><th id="470178436R14" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">15</div></th><td class="s0" dir="ltr">Gene replacement/editing</td><td class="s3" dir="ltr">Restores functional dysferlin protein</td><td class="s3" dir="ltr">Potential for long-term treatment</td><td class="s3" dir="ltr">Technical challenges (due to size of the DYSF gene); risk of immune response</td><td class="s3" dir="ltr">Early clinical trials (gene therapy). Limited to patients with specific mutations</td><td class="s6" dir="ltr"><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></span><br><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.3390/jcm12186011">Bouchard and Tremblay (2023)</a></span></td></tr><tr style="height: 20px"><th id="470178436R15" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">16</div></th><td class="s0" dir="ltr">Antisense-mediated exon skipping</td><td class="s3" dir="ltr">Alters mRNA splicing to bypass mutations</td><td class="s3" dir="ltr">Can restore functional protein</td><td class="s3" dir="ltr">Efficacy varies; potential off-target effects</td><td class="s3" dir="ltr">Early clinical trials. Specific mutations amenable to exon skipping</td><td class="s6" dir="ltr"><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></span><br><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.3390/pharmaceutics15041130">Anwar et al. (2023)</a></span></td></tr><tr style="height: 20px"><th id="470178436R16" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">17</div></th><td class="s0" dir="ltr">Recombinant human MG53 (rhMG53)</td><td class="s3" dir="ltr">Increases integrity of the sarcolemmal membrane in muscle fibers, in a calcium-independent manner.</td><td class="s3" dir="ltr">Improves muscle repair capabilities</td><td class="s3" dir="ltr">Long-term effects unknown</td><td class="s3" dir="ltr">Experimental</td><td class="s6" dir="ltr"><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></span><br><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.1016/j.ymthe.2017.06.025">Gushchina et al. (2017)</a></span></td></tr><tr style="height: 20px"><th id="470178436R17" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">18</div></th><td class="s2" dir="ltr" colspan="6">Cell-based and Tissue Engineering</td></tr><tr style="height: 20px"><th id="470178436R18" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">19</div></th><td class="s0" dir="ltr">Myoblast transplantation</td><td class="s3" dir="ltr">Restoration of dysferlin expression in muscles</td><td class="s3" dir="ltr">Potential restoration of dysferlin expression</td><td class="s3" dir="ltr">Limited migration, immunological issues</td><td class="s3" dir="ltr">Experimental stage. Suitable for localized treatment</td><td class="s4" dir="ltr"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></td></tr><tr style="height: 20px"><th id="470178436R19" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">20</div></th><td class="s0" dir="ltr">Stem Cell Therapies (MSCS, iPSCS)</td><td class="s3" dir="ltr">Differentiation into muscle cells to replace damaged tissue</td><td class="s3" dir="ltr">Theoretical potential for muscle regeneration</td><td class="s3" dir="ltr">Technical challenges in differentiation and delivery</td><td class="s3" dir="ltr">Preclinical stage. Future potential; currently experimental</td><td class="s4" dir="ltr"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></td></tr><tr style="height: 20px"><th id="470178436R20" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">21</div></th><td class="s2" dir="ltr" colspan="6">Dietary and Metabolic Approaches</td></tr><tr style="height: 20px"><th id="470178436R21" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">22</div></th><td class="s0" dir="ltr">Ketogenic diet</td><td class="s3" dir="ltr">Enhances mitochondrial function and muscle repair</td><td class="s3" dir="ltr">Improves mitochondrial function in models</td><td class="s3" dir="ltr">Long-term human efficacy unknown</td><td class="s3" dir="ltr">Dietary intervention; clinical trials needed. Broad applicability with medical supervision</td><td class="s6" dir="ltr"><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></span><br><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.1111/acel.13322">Wallace et al. (2021)</a></span></td></tr><tr style="height: 20px"><th id="470178436R22" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">23</div></th><td class="s7" dir="ltr">AMPK complex activation</td><td class="s8" dir="ltr">Vital for repairing sarcolemmal damage in skeletal muscle fibers. AMPK interact with dysferlin</td><td class="s8" dir="ltr">Important in muscle repair</td><td class="s8" dir="ltr">Limited human data</td><td class="s8" dir="ltr">Preclinical and early clinical trials. Potential for widespread use in muscle repair</td><td class="s9" dir="ltr"><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.3390/biom14030256">Anwar &amp; Yokota (2024)</a></span><br><span style="font-size:12pt;font-family:Roboto,Arial;text-decoration:underline;text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;color:#1155cc;"><a target="_blank" href="https://doi.org/10.1016/j.ymthe.2020.02.006">Ono et al. (2020)</a></span></td></tr></tbody></table></div>